HC Wainwright Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: HC Wainwright
Rating: 2.7
Author: MarketBeat

→ The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at HC Wainwright. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by HC Wainwright.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
NVCT Nuvectis Pharma	$6.43 -10.6%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$21.00	Low	View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 5/8/2024
QURE uniQure	$4.89 +1.5%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 5/8/2024
APLS Apellis Pharmaceuticals	$42.30 -3.6%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$92.00	Low	View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 5/8/2024
EOLS Evolus	$13.26 -1.2%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$27.00	Low	View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 5/8/2024
APLM Apollomics	$0.41 +1.9%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$5.00 -> $2.00	Low	View details for HC Wainwright rating of Apollomics (NASDAQ:APLM) on 5/8/2024
MLTX MoonLake Immunotherapeutics	$42.63 -2.4%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$100.00	Low	View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 5/8/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
OCUL Ocular Therapeutix	$5.75 -3.0%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$16.00 -> $14.00	Low	View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 5/8/2024
DBVT DBV Technologies	$0.69 +2.0%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$10.00 -> $5.00	Low	View details for HC Wainwright rating of DBV Technologies (NASDAQ:DBVT) on 5/8/2024
ZNTL Zentalis Pharmaceuticals	$12.43 +1.0%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$46.00 -> $40.00	Low	View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 5/8/2024
PCRX Pacira BioSciences	$29.65 +11.8%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$57.00	Low	View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 5/8/2024
PTN Palatin Technologies	$2.05 -1.4%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$17.00	N/A	View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 5/8/2024
MDGL Madrigal Pharmaceuticals	$208.04 -4.6%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$425.00 -> $390.00	Low	View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 5/8/2024
CLNN Clene	$0.39 -0.4%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 5/8/2024
CYTK Cytokinetics	$65.27 0.0%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$94.00	Low	View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 5/8/2024
DNLI Denali Therapeutics	$18.90 +12.2%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$95.00	Low	View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 5/8/2024
OPK OPKO Health	$1.25 -3.8%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 5/8/2024
ESPR Esperion Therapeutics	$2.04 -13.9%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$16.00	Low	View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 5/8/2024
ARMP Armata Pharmaceuticals	$2.76 -3.5%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	N/A	View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 5/8/2024
RIGL Rigel Pharmaceuticals	$0.99 -16.6%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 5/8/2024
SRRK Scholar Rock	$14.50 -1.3%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 5/8/2024
VIGL Vigil Neuroscience	$3.78 +18.5%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$24.00	Low	View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/8/2024
ARVN Arvinas	$32.37 -5.7%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$87.00	Low	View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 5/8/2024
URG Ur-Energy	$1.74 -2.8%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$3.40 -> $3.30	N/A	View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 5/8/2024
VALN Valneva	$7.24 -3.5%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$26.00	Low	View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 5/8/2024
CRIS Curis	$16.35 +0.9%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$26.00	Low	View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 5/8/2024
LGND Ligand Pharmaceuticals	$80.26 +9.6%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$144.00	Low	View details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 5/8/2024
BNTX BioNTech	$90.13 -0.8%	5/8/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$107.00 -> $113.00	Low	View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 5/8/2024
GHRS GH Research	$11.99 -0.7%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$40.00	Low	View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 5/7/2024
ENTA Enanta Pharmaceuticals	$12.76 -2.6%	5/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$28.00 -> $27.00	Low	View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 5/7/2024
CIFR Cipher Mining	$3.78 -0.3%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.50 -> $5.50	Low	View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 5/7/2024
AGEN Agenus	$11.47 -4.5%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$40.00	Low	View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 5/7/2024
TVTX Travere Therapeutics	$6.82 +1.0%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$19.00	Low	View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 5/7/2024
MRNS Marinus Pharmaceuticals	$1.43 -8.9%	5/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$27.00 -> $11.00	Low	View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 5/7/2024
ELDN Eledon Pharmaceuticals	$2.44 +8.0%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$13.00 -> $16.00	Low	View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 5/7/2024
LBPH Longboard Pharmaceuticals	$21.70 -1.6%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$60.00	Low	View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 5/7/2024
STOK Stoke Therapeutics	$11.60 -2.8%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$35.00	Low	View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 5/7/2024
ALTO Alto Ingredients	$1.72 -2.3%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.50	Low	View details for HC Wainwright rating of Alto Ingredients (NASDAQ:ALTO) on 5/7/2024
HALO Halozyme Therapeutics	$42.01 +1.9%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 5/7/2024
BCRX BioCryst Pharmaceuticals	$5.10 -3.0%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/7/2024
PLRX Pliant Therapeutics	$13.41 -2.8%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$36.00	Low	View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 5/7/2024
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.
ZYME Zymeworks	$9.06 -0.7%	5/7/2024	Reiterated by	HC Wainwright	-	Neutral -> Neutral	$10.00	Low	View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 5/7/2024
ADCT ADC Therapeutics	$4.41 -8.7%	5/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$9.00 -> $8.00	Low	View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 5/7/2024
AXSM Axsome Therapeutics	$75.68 -1.6%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$190.00	Low	View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/7/2024
RANI Rani Therapeutics	$7.15 -4.2%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$12.00 -> $13.00	Low	View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 5/7/2024
LYEL Lyell Immunopharma	$2.50 -1.6%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 5/7/2024
FHTX Foghorn Therapeutics	$5.98 +6.2%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 5/7/2024
DAWN Day One Biopharmaceuticals	$16.41 -3.9%	5/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$50.00 -> $40.00	Low	View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 5/7/2024
CLDX Celldex Therapeutics	$41.21 -2.4%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$80.00	Low	View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 5/7/2024
CTSO Cytosorbents	$0.87 -6.7%	5/7/2024	Reiterated by	HC Wainwright	Analyst S. Lee	Neutral -> Neutral	$1.00	Low	View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 5/7/2024
GAU Galiano Gold	$1.75	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.30 -> $4.40	N/A	View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 5/7/2024
VIR Vir Biotechnology	$9.54 -3.9%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$110.00	Low	View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 5/7/2024
ALNY Alnylam Pharmaceuticals	$152.29 -1.3%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$395.00 -> $400.00	Low	View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/7/2024
VRTX Vertex Pharmaceuticals	$418.82 +2.1%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$462.00	Low	View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/7/2024
MGX Metagenomi	$6.80 +5.3%	5/7/2024	Initiated by	HC Wainwright	-	Buy	$10.00	Low	View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 5/7/2024
LYRA Lyra Therapeutics	$0.39 -7.2%	5/7/2024	Downgraded by	HC Wainwright	Analyst M. Caufield	Buy -> Neutral	$12.00 -> $2.00	Low	View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 5/7/2024
KRYS Krystal Biotech	$157.68 -2.5%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$200.00	Low	View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 5/6/2024
GLYC GlycoMimetics	$0.30 -2.3%	5/6/2024	Reiterated by	HC Wainwright	Analyst E. White	Buy -> Neutral		N/A	View details for HC Wainwright rating of GlycoMimetics (NASDAQ:GLYC) on 5/6/2024
RGLS Regulus Therapeutics	$2.27 +1.8%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 5/6/2024
GOSS Gossamer Bio	$0.76 +3.9%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 5/6/2024
LCTX Lineage Cell Therapeutics	$1.16 -7.9%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	N/A	View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 5/6/2024
VYNE VYNE Therapeutics	$2.72 -5.9%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.75	Low	View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 5/6/2024
VERU Veru	$1.43 -12.3%	5/6/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$2.00 -> $3.00	Low	View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 5/6/2024
URGN UroGen Pharma	$13.27 -1.3%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$54.00	Low	View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 5/6/2024
NR Newpark Resources	$7.35 -0.3%	5/6/2024	Reiterated by	HC Wainwright	Analyst A. Dayal	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Newpark Resources (NYSE:NR) on 5/6/2024
CRDF Cardiff Oncology	$3.20 -3.3%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$14.00	Low	View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 5/6/2024
BCPC Balchem	$153.28 -1.4%	5/6/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$167.00 -> $170.00	Low	View details for HC Wainwright rating of Balchem (NASDAQ:BCPC) on 5/6/2024
SAND Sandstorm Gold	$5.60 -0.4%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Sandstorm Gold (NYSE:SAND) on 5/6/2024
SWTX SpringWorks Therapeutics	$42.26 -7.6%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$74.00	Low	View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 5/6/2024
ALDX Aldeyra Therapeutics	$4.07 -2.4%	5/6/2024	Reiterated by	HC Wainwright	Analyst M. Caufield	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/6/2024
TARA Protara Therapeutics	$2.83 -1.4%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$23.00	Low	View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 5/6/2024
AEON AEON Biopharma	$1.77 +11.3%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$18.00	Low	View details for HC Wainwright rating of AEON Biopharma (NASDAQ:AEON) on 5/6/2024
CGON CG Oncology	$32.43 -4.5%	5/6/2024	Reiterated by	HC Wainwright	Analyst A. Maldonado	Buy -> Buy	$75.00	Low	View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 5/6/2024
HOWL Werewolf Therapeutics	$5.48 -4.2%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Werewolf Therapeutics (NASDAQ:HOWL) on 5/6/2024
FNV Franco-Nevada	$126.34 +0.2%	5/6/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$175.00 -> $185.00	Low	View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 5/6/2024
JSPR Jasper Therapeutics	$21.19 -6.9%	5/6/2024	Initiated by	HC Wainwright	-	Buy	$65.00	Low	View details for HC Wainwright rating of Jasper Therapeutics (NASDAQ:JSPR) on 5/6/2024
EU enCore Energy	$4.73 -4.3%	5/6/2024	Initiated by	HC Wainwright	Analyst H. Ihle	Buy	$7.50	Low	View details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 5/6/2024
PBYI Puma Biotechnology	$4.83 +1.7%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Puma Biotechnology (NASDAQ:PBYI) on 5/3/2024
BCYC Bicycle Therapeutics	$23.62 +2.3%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$55.00	Low	View details for HC Wainwright rating of Bicycle Therapeutics (NASDAQ:BCYC) on 5/3/2024
JAZZ Jazz Pharmaceuticals	$110.70 -0.5%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$200.00	Low	View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 5/3/2024
KALV KalVista Pharmaceuticals	$12.06 -1.1%	5/3/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$24.00 -> $20.00	Low	View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 5/3/2024
DYN Dyne Therapeutics	$25.69 +0.2%	5/3/2024	Reiterated by	HC Wainwright	Analyst A. Fein	Buy -> Buy	$36.00	Low	View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 5/3/2024
BMEA Biomea Fusion	$11.07 -7.8%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 5/3/2024
KURA Kura Oncology	$20.55 -2.5%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 5/3/2024
LIFE aTyr Pharma	$1.69 -0.6%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$35.00	Low	View details for HC Wainwright rating of aTyr Pharma (NASDAQ:LIFE) on 5/3/2024
SCLX Scilex	$0.85 -7.7%	5/3/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$12.00 -> $8.00	Low	View details for HC Wainwright rating of Scilex (NASDAQ:SCLX) on 5/3/2024
KRON Kronos Bio	$1.04 -1.0%	5/3/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$2.50 -> $2.25	Low	View details for HC Wainwright rating of Kronos Bio (NASDAQ:KRON) on 5/3/2024
EXEL Exelixis	$21.59 -2.5%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$28.00	Low	View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 5/3/2024
NGNE Neurogene	$32.90 -3.1%	5/3/2024	Reiterated by	HC Wainwright	Analyst M. Kapoor	Buy -> Buy	$55.00	Low	View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 5/3/2024
NXTC NextCure	$1.58	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 5/3/2024
BPMC Blueprint Medicines	$108.78 +0.2%	5/3/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$125.00 -> $135.00	Low	View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 5/3/2024
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.
XPL Solitario Resources	$0.80	5/3/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$0.80 -> $1.10	N/A	View details for HC Wainwright rating of Solitario Resources (NYSEAMERICAN:XPL) on 5/3/2024
BBAI BigBear.ai	$1.49 +0.7%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of BigBear.ai (NYSE:BBAI) on 5/3/2024
GEVO Gevo	$0.75 +1.3%	5/3/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$14.00	Low	View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 5/3/2024
ASPN Aspen Aerogels	$26.63 +1.4%	5/3/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$20.00 -> $25.00	Low	View details for HC Wainwright rating of Aspen Aerogels (NYSE:ASPN) on 5/3/2024
STTK Shattuck Labs	$10.49 -2.4%	5/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$28.00	Low	View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 5/2/2024
PTN Palatin Technologies	$2.05 -1.4%	5/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$17.00	N/A	View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 5/2/2024
TGTX TG Therapeutics	$17.12 -0.3%	5/2/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$45.00 -> $49.00	Low	View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 5/2/2024
ALKS Alkermes	$24.10 -2.0%	5/2/2024	Reiterated by	HC Wainwright	-	Neutral -> Neutral	$35.00	Low	View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 5/2/2024
NERV Minerva Neurosciences	$2.51 +0.8%	5/2/2024	Target Lowered by	HC Wainwright	-	Neutral -> Neutral	$11.00 -> $7.00	Low	View details for HC Wainwright rating of Minerva Neurosciences (NASDAQ:NERV) on 5/2/2024
CORT Corcept Therapeutics	$25.40 +3.8%	5/2/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$38.00 -> $40.00	Low	View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 5/2/2024
PSTX Poseida Therapeutics	$2.71 -7.2%	5/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 5/2/2024
GTHX G1 Therapeutics	$4.29 +0.9%	5/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of G1 Therapeutics (NASDAQ:GTHX) on 5/2/2024
NVCR NovoCure	$16.03 +3.2%	5/2/2024	Target Lowered by	HC Wainwright	-	Neutral -> Neutral	$24.00 -> $22.00	Low	View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 5/2/2024
UTHR United Therapeutics	$261.09 -1.9%	5/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$300.00	Low	View details for HC Wainwright rating of United Therapeutics (NASDAQ:UTHR) on 5/2/2024
NBIX Neurocrine Biosciences	$139.02 -2.9%	5/2/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$150.00 -> $160.00	Low	View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/2/2024
BLCO Bausch + Lomb	$14.81 -0.6%	5/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 5/2/2024
SGMT Sagimet Biosciences	$4.44 +2.5%	5/2/2024	Initiated by	HC Wainwright	Analyst E. Arce	Buy	$32.00	Low	View details for HC Wainwright rating of Sagimet Biosciences (NASDAQ:SGMT) on 5/2/2024
RIOT Riot Platforms	$10.35 +1.8%	5/1/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$20.00 -> $17.00	N/A	View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 5/1/2024
LGO Largo	$1.56 -6.6%	5/1/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.60 -> $4.70	Low	View details for HC Wainwright rating of Largo (NYSE:LGO) on 5/1/2024
CYTH Cyclo Therapeutics	$1.50 -0.7%	5/1/2024	Initiated by	HC Wainwright	Analyst S. Ramakanth	Buy	$3.00	Low	View details for HC Wainwright rating of Cyclo Therapeutics (NASDAQ:CYTH) on 5/1/2024
PYPD PolyPid	$4.31 -11.3%	5/1/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$14.00	Low	View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 5/1/2024
LYRA Lyra Therapeutics	$0.39 -7.2%	5/1/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 5/1/2024
ZYXI Zynex	$10.73 -1.9%	5/1/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$21.00	Low	View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 5/1/2024
CECO CECO Environmental	$24.44 +3.9%	5/1/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 5/1/2024
XOMA XOMA	$24.20 -1.3%	5/1/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$74.00	Low	View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 5/1/2024
DARE Daré Bioscience	$0.31 -0.9%	5/1/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 5/1/2024
MDXG MiMedx Group	$7.20 -1.2%	5/1/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of MiMedx Group (NASDAQ:MDXG) on 5/1/2024
FHTX Foghorn Therapeutics	$5.98 +6.2%	5/1/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 5/1/2024
TERN Terns Pharmaceuticals	$6.05 +5.0%	4/30/2024	Reiterated by	HC Wainwright	-	Neutral -> Neutral	$5.50	Low	View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 4/30/2024
OMGA Omega Therapeutics	$2.14 -0.5%	4/30/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Omega Therapeutics (NASDAQ:OMGA) on 4/30/2024
GMAB Genmab A/S	$28.80 -1.7%	4/30/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 4/30/2024
ANVS Annovis Bio	$4.82 -9.9%	4/30/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 4/30/2024
AQST Aquestive Therapeutics	$3.09 -8.6%	4/30/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 4/30/2024
HALO Halozyme Therapeutics	$42.01 +1.9%	4/30/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 4/30/2024
ITRM Iterum Therapeutics	$1.60 +3.2%	4/30/2024	Reiterated by	HC Wainwright	Analyst E. Arce	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 4/30/2024
EKSO Ekso Bionics	$1.38 +0.7%	4/30/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$9.25 -> $10.00	Low	View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 4/30/2024
XFOR X4 Pharmaceuticals	$1.04 -4.6%	4/30/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$3.00 -> $5.00	Low	View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 4/30/2024
NBTX Nanobiotix	$6.90 +7.6%	4/26/2024	Reiterated by	HC Wainwright	Analyst S. Ramakanth	Buy		Low	View details for HC Wainwright rating of Nanobiotix (NASDAQ:NBTX) on 4/26/2024
AVBP ArriVent BioPharma	$17.36 +0.6%	4/30/2024	Initiated by	HC Wainwright	Analyst R. Burns	Buy	$25.00	Low	View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 4/30/2024
ADVM Adverum Biotechnologies	$9.81 -5.1%	4/30/2024	Initiated by	HC Wainwright	Analyst M. Caufield	Buy	$30.00	Low	View details for HC Wainwright rating of Adverum Biotechnologies (NASDAQ:ADVM) on 4/30/2024
GAU Galiano Gold	$1.75	4/29/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$2.20 -> $4.30	N/A	View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 4/29/2024
COIN Coinbase Global	$211.20 -1.5%	4/29/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$250.00 -> $300.00	Low	View details for HC Wainwright rating of Coinbase Global (NASDAQ:COIN) on 4/29/2024
ATNM Actinium Pharmaceuticals	$8.71 -1.1%	4/29/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	N/A	View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/29/2024
OVID Ovid Therapeutics	$3.09 +3.0%	4/29/2024	Initiated by	HC Wainwright	Analyst R. Selvaraju	Buy	$9.00	Low	View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 4/29/2024
OPTN OptiNose	$1.04 +1.0%	4/29/2024	Reiterated by	HC Wainwright	Analyst M. Caufield	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 4/29/2024
SAGE Sage Therapeutics	$12.39 -4.5%	4/26/2024	Target Lowered by	HC Wainwright	-	Neutral -> Neutral	$28.00 -> $25.00	Low	View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 4/26/2024
APLS Apellis Pharmaceuticals	$42.30 -3.6%	4/26/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$92.00	Low	View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/26/2024
PPBT Purple Biotech	$0.55 +7.8%	4/26/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Purple Biotech (NASDAQ:PPBT) on 4/26/2024
HOOK Hookipa Pharma	$0.80 -3.3%	4/26/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$6.50 -> $5.00	Low	View details for HC Wainwright rating of Hookipa Pharma (NASDAQ:HOOK) on 4/26/2024
BPMC Blueprint Medicines	$108.78 +0.2%	4/26/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$125.00	Low	View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 4/26/2024
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad) See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space. Click to read
PRAX Praxis Precision Medicines	$50.75 -3.1%	4/26/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$105.00	Low	View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 4/26/2024
SNDX Syndax Pharmaceuticals	$22.38 -3.5%	4/26/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$41.00	Low	View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 4/26/2024
ARBK Argo Blockchain	$1.35 -0.7%	4/26/2024	Downgraded by	HC Wainwright	Analyst K. Dede	Buy -> Neutral		Low	View details for HC Wainwright rating of Argo Blockchain (NASDAQ:ARBK) on 4/26/2024
LSTA Lisata Therapeutics	$2.80 +1.8%	4/25/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 4/25/2024
MAG MAG Silver	$12.61 -0.8%	4/25/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$16.00 -> $17.00	N/A	View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 4/25/2024
URG Ur-Energy	$1.74 -2.8%	4/25/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$3.60 -> $3.40	N/A	View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 4/25/2024
LTRN Lantern Pharma	$6.48 +0.9%	4/25/2024	Reiterated by	HC Wainwright	-	Neutral		Low	View details for HC Wainwright rating of Lantern Pharma (NASDAQ:LTRN) on 4/25/2024
GANX Gain Therapeutics	$2.68 -7.6%	4/25/2024	Reiterated by	HC Wainwright	Analyst R. Selvaraju	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 4/25/2024
EVO Evotec	$5.19 +1.0%	4/25/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$14.00 -> $11.00	Low	View details for HC Wainwright rating of Evotec (NASDAQ:EVO) on 4/25/2024
VKTX Viking Therapeutics	$79.91 +0.4%	4/25/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$90.00	Low	View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 4/25/2024
XOMA XOMA	$24.20 -1.3%	4/25/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$74.00	Low	View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 4/25/2024
CAPR Capricor Therapeutics	$5.37 -1.6%	4/25/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$40.00	Low	View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 4/25/2024
ACRV Acrivon Therapeutics	$8.23 -1.3%	4/25/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 4/25/2024
BIIB Biogen	$219.72 +0.4%	4/25/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$325.00 -> $300.00	Low	View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 4/25/2024
TVTX Travere Therapeutics	$6.82 +1.0%	4/24/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$17.00 -> $19.00	Low	View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 4/24/2024
NBIX Neurocrine Biosciences	$139.02 -2.9%	4/24/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$150.00	Low	View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024
DAWN Day One Biopharmaceuticals	$16.41 -3.9%	4/24/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 4/24/2024
CLIR ClearSign Technologies	$0.81 -1.2%	4/24/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of ClearSign Technologies (NASDAQ:CLIR) on 4/24/2024
AEYE AudioEye	$18.68 -2.1%	4/24/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$17.00	Low	View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/24/2024
OCS Oculis	$12.37 -2.1%	4/24/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$29.00 -> $28.00	Low	View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 4/24/2024
CORT Corcept Therapeutics	$25.40 +3.8%	4/23/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$38.00	Low	View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 4/23/2024
GROY Gold Royalty	$1.79 -2.7%	4/23/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.75	N/A	View details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 4/23/2024
LEGN Legend Biotech	$45.72 -0.6%	4/23/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$87.00	Low	View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/23/2024
ATXS Astria Therapeutics	$9.57 -4.1%	4/23/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$18.00 -> $16.00	Low	View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 4/23/2024
MLTX MoonLake Immunotherapeutics	$42.63 -2.4%	4/23/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$100.00	Low	View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 4/23/2024
BTAI BioXcel Therapeutics	$2.12 -9.8%	4/23/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 4/23/2024
ENLV Enlivex Therapeutics	$1.55 -1.9%	4/23/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/23/2024
RNAC Cartesian Therapeutics	$23.25 +0.2%	4/23/2024	Target Raised by	HC Wainwright	Analyst M. Kapoor	Buy -> Buy	$2.00 -> $54.00	Low	View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/23/2024
KURA Kura Oncology	$20.55 -2.5%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 4/22/2024
RIOT Riot Platforms	$10.35 +1.8%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	N/A	View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 4/22/2024
KRYS Krystal Biotech	$157.68 -2.5%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$200.00	Low	View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 4/22/2024
CRDL Cardiol Therapeutics	C$2.75 +0.4%	4/22/2024	Reiterated by	HC Wainwright	-	Buy		N/A	View details for HC Wainwright rating of Cardiol Therapeutics (TSE:CRDL) on 4/22/2024
CLMT Calumet Specialty Products Partners	$16.11 -1.2%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 4/22/2024
RVPH Reviva Pharmaceuticals	$2.82 +0.7%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/22/2024
LYTS LSI Industries	$15.87 +4.3%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of LSI Industries (NASDAQ:LYTS) on 4/22/2024
PHGE BiomX	$0.37 -7.5%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$2.00	N/A	View details for HC Wainwright rating of BiomX (NYSEMKT:PHGE) on 4/22/2024
ROIV Roivant Sciences	$11.21 -1.5%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$18.00	Low	View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 4/22/2024
PSTX Poseida Therapeutics	$2.71 -7.2%	4/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 4/22/2024
CRDL Cardiol Therapeutics	$2.00 +1.0%	4/22/2024	Initiated by	HC Wainwright	Analyst V. Bernardino	Buy	$9.00	Low	View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 4/22/2024
BRNS Barinthus Biotherapeutics	$2.27	4/19/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 4/19/2024
AG First Majestic Silver	$7.11 -1.9%	4/19/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$7.00 -> $8.50	Low	View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 4/19/2024
ALKS Alkermes	$24.10 -2.0%	4/19/2024	Reiterated by	HC Wainwright	-	Neutral -> Neutral	$35.00	Low	View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 4/19/2024
OCUL Ocular Therapeutix	$5.75 -3.0%	4/19/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$16.00	Low	View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 4/19/2024
TGTX TG Therapeutics	$17.12 -0.3%	4/18/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$45.00	Low	View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 4/18/2024
URGN UroGen Pharma	$13.27 -1.3%	4/18/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$54.00	Low	View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 4/18/2024
BEEM Beam Global	$6.30 -0.9%	4/18/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of Beam Global (NASDAQ:BEEM) on 4/18/2024
IGMS IGM Biosciences	$9.34 -5.9%	4/18/2024	Reiterated by	HC Wainwright	Analyst R. Burns	Neutral -> Neutral	$12.00	Low	View details for HC Wainwright rating of IGM Biosciences (NASDAQ:IGMS) on 4/18/2024
ASM Avino Silver & Gold Mines	$0.72 -1.1%	4/18/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$1.50 -> $1.60	Low	View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/18/2024
ASM Avino Silver & Gold Mines	$0.73 -1.4%	4/18/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$1.50 -> $1.60	Low	View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/18/2024
ARGX argenx	$386.08 -3.2%	4/18/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$451.00	Low	View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 4/18/2024
BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad) BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it. Discover the name and ticker of this $2 stock here >>>
AEYE AudioEye	$18.68 -2.1%	4/18/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$10.00 -> $17.00	Low	View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/18/2024
ASND Ascendant Resources	C$0.07 -7.1%	4/17/2024	Target Raised by	HC Wainwright	-		C$0.30 -> C$0.35	N/A	View details for HC Wainwright rating of Ascendant Resources (TSE:ASND) on 4/17/2024
MSL Merus Labs International	C$1.65 +0.6%	4/15/2024	Reiterated by	HC Wainwright	Analyst A. He	Buy		N/A	View details for HC Wainwright rating of Merus Labs International (TSE:MSL) on 4/15/2024
BNTX BioNTech	$90.13 -0.8%	4/17/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$107.00	Low	View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 4/17/2024
ASPI ASP Isotopes	$3.62 +0.8%	4/17/2024	Target Raised by	HC Wainwright	Analyst H. Ihle	Buy -> Buy	$5.25 -> $5.50	Low	View details for HC Wainwright rating of ASP Isotopes (NASDAQ:ASPI) on 4/17/2024
CNTB Connect Biopharma	$1.45 -4.6%	4/17/2024	Target Raised by	HC Wainwright	Analyst E. Bodnar	Buy -> Buy	$7.00 -> $8.00	Low	View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 4/17/2024
CLNN Clene	$0.39 -0.4%	4/17/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 4/17/2024
AEON AEON Biopharma	$1.77 +11.3%	4/17/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$18.00	Low	View details for HC Wainwright rating of AEON Biopharma (NASDAQ:AEON) on 4/17/2024
CLDX Celldex Therapeutics	$41.21 -2.4%	4/17/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$80.00	N/A	View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 4/17/2024
HALO Halozyme Therapeutics	$42.01 +1.9%	4/17/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	N/A	View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 4/17/2024
SAGE Sage Therapeutics	$12.39 -4.5%	4/17/2024	Reiterated by	HC Wainwright	-	Neutral -> Neutral	$28.00	N/A	View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 4/17/2024
DTIL Precision BioSciences	$11.27 +6.6%	4/17/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$60.00	N/A	View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 4/17/2024
BLRX BioLineRx	$0.66 -3.3%	4/17/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$21.00	N/A	View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 4/17/2024
SABS SAB Biotherapeutics	$4.10 +0.2%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024
CMPX Compass Therapeutics	$1.58 -6.0%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 4/16/2024
CGEM Cullinan Oncology	$27.72 -5.6%	4/16/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$34.00 -> $29.00	Low	View details for HC Wainwright rating of Cullinan Oncology (NASDAQ:CGEM) on 4/16/2024
LEGN Legend Biotech	$45.72 -0.6%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$87.00	Low	View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/16/2024
MRNS Marinus Pharmaceuticals	$1.43 -8.9%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$27.00	Low	View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/16/2024
ATOS Atossa Therapeutics	$1.68 -1.2%	4/16/2024	Reiterated by	HC Wainwright	Analyst E. Bodnar	Buy -> Buy	$4.00	Low	View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 4/16/2024
ICCM IceCure Medical	$1.17 -3.3%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 4/16/2024
TRNS Transcat	$115.21 +0.7%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$124.00	Low	View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 4/16/2024
MITK Mitek Systems	$13.38 -0.1%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$19.00	Low	View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 4/16/2024
LBPH Longboard Pharmaceuticals	$21.70 -1.6%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$60.00	Low	View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/16/2024
VIRX Viracta Therapeutics	$0.82 +0.1%	4/16/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.00	Low	View details for HC Wainwright rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/16/2024
TRX TRX Gold	$0.45 +0.5%	4/16/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$1.30 -> $1.40	Low	View details for HC Wainwright rating of TRX Gold (NYSE:TRX) on 4/16/2024
UBX Unity Biotechnology	$1.63 +0.6%	4/16/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$10.00 -> $8.00	Low	View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 4/16/2024
MBOT Microbot Medical	$0.91 -4.4%	4/16/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$8.00 -> $7.00	Low	View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 4/16/2024
LFWD ReWalk Robotics	$5.16 +7.1%	4/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 4/15/2024
INDP Indaptus Therapeutics	$2.07 +1.0%	4/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Indaptus Therapeutics (NASDAQ:INDP) on 4/15/2024
ONCT Oncternal Therapeutics	$8.56 +0.5%	4/15/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$30.00 -> $28.00	Low	View details for HC Wainwright rating of Oncternal Therapeutics (NASDAQ:ONCT) on 4/15/2024
APLS Apellis Pharmaceuticals	$42.30 -3.6%	4/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$92.00	Low	View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/15/2024
CLSK CleanSpark	$16.37 -1.0%	4/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$27.00	Low	View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 4/15/2024
ADCT ADC Therapeutics	$4.41 -8.7%	4/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 4/15/2024
ENLV Enlivex Therapeutics	$1.55 -1.9%	4/12/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$12.00 -> $7.00	Low	View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/12/2024
ARVN Arvinas	$32.37 -5.7%	4/12/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$90.00 -> $87.00	Low	View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 4/12/2024
ALPN Alpine Immune Sciences	$64.70 +0.1%	4/11/2024	Downgraded by	HC Wainwright	Analyst J. Pantginis	Buy -> Neutral		Low	View details for HC Wainwright rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/11/2024
MLTX MoonLake Immunotherapeutics	$42.63 -2.4%	4/11/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$100.00	Low	View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 4/11/2024
IPHA Innate Pharma	$2.63 +2.3%	4/11/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.50	Low	View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 4/11/2024
VRTX Vertex Pharmaceuticals	$418.82 +2.1%	4/11/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$457.00 -> $462.00	Low	View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/11/2024
INAB IN8bio	$1.01	4/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$14.00	Low	View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 4/10/2024
ALXO ALX Oncology	$16.61 -5.4%	4/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 4/10/2024
PYXS Pyxis Oncology	$4.27 -2.5%	4/10/2024	Reiterated by	HC Wainwright	Analyst S. Ramakanth	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 4/10/2024
FHTX Foghorn Therapeutics	$5.98 +6.2%	4/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 4/10/2024
RAPT RAPT Therapeutics	$7.98 -1.2%	4/10/2024	Reiterated by	HC Wainwright	Analyst R. Selvaraju	Neutral		Low	View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 4/10/2024
GALT Galectin Therapeutics	$3.24 -3.3%	4/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 4/9/2024
ELEV Elevation Oncology	$3.58 +2.9%	4/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 4/9/2024
CDTX Cidara Therapeutics	$13.05 -2.9%	4/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$120.00	Low	View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/8/2024
VERV Verve Therapeutics	$6.08 -1.3%	4/8/2024	Initiated by	HC Wainwright	Analyst M. Kapoor	Buy	$15.00	Low	View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 4/8/2024
AMLX Amylyx Pharmaceuticals	$1.93 -2.0%	4/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 4/8/2024
TARA Protara Therapeutics	$2.83 -1.4%	4/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$23.00	Low	View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 4/8/2024
GNFT Genfit	$3.59 +1.1%	4/5/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Genfit (NASDAQ:GNFT) on 4/5/2024
CLGN CollPlant Biotechnologies	$6.24 +5.6%	4/5/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 4/5/2024
AQST Aquestive Therapeutics	$3.09 -8.6%	4/5/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 4/5/2024
GMAB Genmab A/S	$28.80 -1.7%	4/4/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 4/4/2024
AMPX Amprius Technologies	$2.16 +4.3%	4/4/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Amprius Technologies (NYSE:AMPX) on 4/4/2024
MIGI Mawson Infrastructure Group	$1.21 +6.1%	4/4/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/4/2024
ASXC Asensus Surgical	$0.25 +1.0%	4/4/2024	Downgraded by	HC Wainwright	Analyst S. Ramakanth	Buy -> Neutral	$2.00 -> $0.35	N/A	View details for HC Wainwright rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 4/4/2024
CGON CG Oncology	$32.43 -4.5%	4/4/2024	Reiterated by	HC Wainwright	Analyst A. Maldonado	Buy -> Buy	$75.00	Low	View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 4/4/2024
MAG MAG Silver	$12.61 -0.8%	4/4/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$19.50 -> $16.00	N/A	View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 4/4/2024
FENC Fennec Pharmaceuticals	$9.27 -0.9%	4/4/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$17.00 -> $18.00	Low	View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 4/4/2024

MarketBeat Community Rating for HC Wainwright

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		25,030 (Thanks for Voting!)
Underperform Votes:		21,745 (Thanks for Voting!)
Total Votes:		46,775

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

HC Wainwright Analyst Recommendations & Stock Picks

MarketBeat Community Rating for HC Wainwright

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info